Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
Open Access
- 3 December 2024
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 233, 106046
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Volkswagen Foundation
- Lower Saxony State Ministry of Science and Culture
This publication has 70 references indexed in Scilit:
- Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological ApproachesInfectious Diseases and Therapy, 2024
- Dexamethasone for Inpatients With COVID-19 in a National CohortJAMA Network Open, 2023
- Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2Protein & Cell, 2020
- Potent in vitro activity of β-D-4ʹ-chloromethyl-2ʹ-deoxy-2ʹ-fluorocytidine against Nipah virusAntiviral Research, 2020
- Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responsesAntiviral Research, 2018
- Susceptibility of paramyxoviruses and filoviruses to inhibition by 2′-monofluoro- and 2′-difluoro-4′-azidocytidine analogsAntiviral Research, 2018
- Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomideBiochemical Pharmacology, 1995
- Infectious rabies viruses from cloned cDNA.The EMBO Journal, 1994
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedeberg's Archives of Pharmacology, 1931